Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung

The standard-of-care for advanced small cell lung cancer (SCLC) is chemotherapy with cisplatin+etoposide (C+E). Most patients have chemosensitive disease at the outset, but disease frequently relapses and limits survival. Efforts to improve therapeutic outcomes in SCLC and other neuroendocrine cance...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Anticancer Drugs
Autores principales: Balasubramaniam, Sanjeeve, Redon, Christophe E., Peer, Cody J., Bryla, Christine, Lee, Min-Jung, Trepel, Jane B., Tomita, Yusuke, Rajan, Arun, Giaccone, Giuseppe, Bonner, William M., Figg, William D., Fojo, Tito, Piekarz, Richard L., Bates, Susan E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6631369/
https://ncbi.nlm.nih.gov/pubmed/29420340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000596
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares